307 related articles for article (PubMed ID: 35053593)
1. Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
Marchese U; Gaillard M; Pellat A; Tzedakis S; Abou Ali E; Dohan A; Barat M; Soyer P; Fuks D; Coriat R
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053593
[TBL] [Abstract][Full Text] [Related]
2. Parenchymal Sparing Resection: Options in Duodenal and Pancreatic Surgery.
Marchese U; Tzedakis S; Abou Ali E; Turrini O; Delpero JR; Coriat R; Fuks D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918376
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review.
Zappi A; Persano I; Galvani L; Parlagreco E; Andrini E; Campana D; Brizzi MP; Lamberti G; La Salvia A
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675645
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.
Xu JX; Wu DH; Ying LW; Hu HG
World J Gastroenterol; 2021 Dec; 27(47):8123-8137. PubMed ID: 35068858
[TBL] [Abstract][Full Text] [Related]
6. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
8. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
9. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract][Full Text] [Related]
10. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of benign, premalignant and low-risk tumors of the pancreas : Standard resection or parenchyma preserving, local extirpation].
Beger HG
Chirurg; 2016 Jul; 87(7):579-84. PubMed ID: 26943167
[TBL] [Abstract][Full Text] [Related]
12. Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons.
Beger HG
J Gastrointest Surg; 2018 Mar; 22(3):562-566. PubMed ID: 29299757
[TBL] [Abstract][Full Text] [Related]
13. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
[TBL] [Abstract][Full Text] [Related]
14. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.
Calabrò D; Argalia G; Ambrosini V
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297381
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
Karakaş Y; Laçin Ş; Kurtulan O; Esin E; Sunar V; Sökmensüer C; Kılıçkap S; Yalçin Ş
Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
[TBL] [Abstract][Full Text] [Related]
16. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
17. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.
Dralle H; Krohn SL; Karges W; Boehm BO; Brauckhoff M; Gimm O
World J Surg; 2004 Dec; 28(12):1248-60. PubMed ID: 15517487
[TBL] [Abstract][Full Text] [Related]
18. Ampullary and Pancreatic Neuroendocrine Tumors: A Series of Cases and Review of the Literature.
Matli VVK; Wellman G; Jaganmohan S; Koticha K
Cureus; 2022 Jan; 14(1):e21657. PubMed ID: 35111492
[TBL] [Abstract][Full Text] [Related]
19. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
[TBL] [Abstract][Full Text] [Related]
20. A well differentiated neuroendocrine tumor of the jejunum with peritoneal carcinomatosis: A case report.
Antoniadou F; Korkolis D; Koufopoulos N; Manatakis D; Sakellariou S
Mol Clin Oncol; 2018 Dec; 9(6):651-655. PubMed ID: 30546896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
